This CME-certified activity is based on information presented at a CME satellite symposium held on December 14, 2012 in Hollywood, Florida.

Activity Overview
Crohn’s disease is a chronic, inflammatory disorder that can become disabling over time. Because it is a lifelong disease, the importance of maintaining symptomatic control and remission is critical to minimizing short- and long-term complications and improving outcomes and quality of life for patients. To help improve outcomes for patients with Crohn’s disease, the concept of mucosal healing (also referred to as sustained biologic remission) has been put forth as a therapeutic end point designed to show that treatment has reduced the intestinal mucosal damage that frequently accompanies Crohn’s disease.


This activity has been designed to meet the educational needs of gastroenterologists and other health care professionals involved in the care of patients with Crohn’s disease.


Upon completion of this activity, participants should be able to:

— Discuss the clinical benefits of mucosal healing in patients with Crohn’s disease

— Design an effective treatment plan that maximizes the occurrence of mucosal healing in patients with Crohn’s disease

—Evaluate the clinical utility of biomarkers for the assessment of mucosal healing in patients with Crohn’s disease 



    Stephen B. Hanauer, MD—Program Chair

    Professor of Medicine and Clinical Pharmacology
    Chief, Section of Gastroenterology and Nutrition
    University of Chicago Medicine
    Chicago, Illinois

    William J. Sandborn, MD—Program Chair
    Clinical Professor of Medicine
    Chief, Division of Gastroenterology
    Director, Inflammatory Bowel Disease Center
    University of California San Diego
    La Jolla, California

    David T. Rubin, MD
    Professor of Medicine
    Co-Director, Inflammatory Bowel Disease Center
    Associate Section Chief, Education
    Section of Gastroenterology, Hepatology and Nutrition
    University of Chicago Medicine
    Chicago, Illinois

    Corey A. Siegel, MD, MS
    Assistant Professor of Medicine
    The Dartmouth Institute for Health Policy and Clinical Practice
    Geisel School of Medicine at Dartmouth
    Section of Gastroenterology and Hepatology
    Director, Inflammatory Bowel Disease Center
    Dartmouth-Hitchcock Medical Center

    Lebanon, New Hampshire

    To take this course, go to The log-in information for myCME is the same as McKnight’s. Please note that you will need to complete additional registration information.